Neueste Veröffentlichungen

• Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
  Article (Journal), Online Resource
• The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature
  Article (Journal), Online Resource
• Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the treatment of high-risk newly diagnosed multiple myeloma
  Article (Journal), Online Resource
• Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
  Article (Journal), Online Resource
• CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
  Article (Journal), Online Resource

Alle anzeigen (88)
Alle anzeigen (inkl. Paralleltitel) (90)

Co-Autoren

• Goldschmidt, Hartmut
• Ho, Anthony Dick
• Hose, Dirk
• Raab, Marc-Steffen
• Müller-Tidow, Carsten

Alle anzeigen (1033)

Publikationsjahre

Publikationstypen